Gu, J., Wang, L., Lin, H., Chen, D., Tang, H., Jin, X., . . . Zhang, Z. (2015). The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data. Acta Pharmacol Sin.
Chicago Style aipamenaGu, Jie-mei, et al. "The Efficacy and Safety of Weekly 35-mg Risedronate Dosing Regimen for Chinese Postmenopausal Women With Osteoporosis or Osteopenia: 1-year Data." Acta Pharmacol Sin 2015.
MLA aipamenaGu, Jie-mei, et al. "The Efficacy and Safety of Weekly 35-mg Risedronate Dosing Regimen for Chinese Postmenopausal Women With Osteoporosis or Osteopenia: 1-year Data." Acta Pharmacol Sin 2015.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.